$VMNT
Vemanti Group, Inc.

2022 Q2 Form 10-Q Financial Statement

#000147793222003338 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q1
Revenue $36.18K $37.60K
YoY Change -3.99%
Cost Of Revenue $6.652K $5.520K
YoY Change 31.75%
Gross Profit $29.53K $32.08K
YoY Change -9.52%
Gross Profit Margin 81.61% 85.32%
Selling, General & Admin $293.8K $329.0K
YoY Change -37.7%
% of Gross Profit 995.02% 1025.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $190.00 $184.00 $185.00
YoY Change -48.65% -0.54%
% of Gross Profit 0.64% 0.57%
Operating Expenses $293.8K $328.9K
YoY Change -37.7%
Operating Profit -$264.3K -$296.9K
YoY Change -39.79%
Interest Expense $13.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $186.00 $436.00 -$1.651K
YoY Change -89.37% -126.41%
Pretax Income -$264.3K -$296.4K -$69.97K
YoY Change -40.41% 323.68%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$264.3K -$296.4K -$69.97K
YoY Change -40.52% 323.68% 105.36%
Net Earnings / Revenue -730.48% -788.39%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 71.70M shares 70.95M shares
Diluted Shares Outstanding 71.68M shares 70.95M shares 69.15M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $435.8K $540.9K
YoY Change -5.08%
Cash & Equivalents $435.8K $534.8K $435.6K
Short-Term Investments $0.00 $6.110K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $7.606K $1.410K
Other Receivables $0.00 $25.14K
Total Short-Term Assets $443.4K $567.4K
YoY Change -9.18%
LONG-TERM ASSETS
Property, Plant & Equipment $261.00 $450.00
YoY Change -73.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $296.4K
YoY Change -100.0%
Total Long-Term Assets $321.8K $296.9K
YoY Change 8.2%
TOTAL ASSETS
Total Short-Term Assets $443.4K $567.4K
Total Long-Term Assets $321.8K $296.9K
Total Assets $765.3K $864.3K
YoY Change -2.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.23K $10.18K
YoY Change 98.95%
Accrued Expenses $342.8K $279.8K
YoY Change 119.24%
Deferred Revenue
YoY Change
Short-Term Debt $125.0K $125.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $488.1K $415.0K
YoY Change 193.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $488.1K $415.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $488.1K $415.0K
YoY Change 193.05%
SHAREHOLDERS EQUITY
Retained Earnings -$3.845M -$3.581M
YoY Change 76.91%
Common Stock $7.170K $7.151K
YoY Change 2.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $277.2K $449.3K $762.0K
YoY Change
Total Liabilities & Shareholders Equity $765.3K $864.3K
YoY Change -2.6%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$264.3K -$296.4K -$69.97K
YoY Change -40.52% 323.68% 105.36%
Depreciation, Depletion And Amortization $190.00 $184.00 $185.00
YoY Change -48.65% -0.54%
Cash From Operating Activities -$104.8K -$98.65K -$62.87K
YoY Change -46.65% 56.9%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $5.890K
YoY Change
Cash From Investing Activities $5.890K $0.00 -$10.00K
YoY Change -158.9% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $337.5K $265.0K
YoY Change 27.36%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $337.5K $265.0K
YoY Change -100.0% 27.36%
NET CHANGE
Cash From Operating Activities -104.8K -$98.65K -$62.87K
Cash From Investing Activities 5.890K $0.00 -$10.00K
Cash From Financing Activities 0.000 $337.5K $265.0K
Net Change In Cash -98.94K $238.9K $192.1K
YoY Change -147.45% 24.32%
FREE CASH FLOW
Cash From Operating Activities -$104.8K -$98.65K -$62.87K
Capital Expenditures $0.00
Free Cash Flow -$98.65K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71704004 shares
CY2022Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
6107 USD
CY2021Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
6107 USD
CY2022Q1 vemanti Loan From Stockholder
LoanFromStockholder
125000 USD
CY2021Q4 vemanti Loan From Stockholder
LoanFromStockholder
125000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
414998 USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4018669 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3580522 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
449298 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
864296 USD
CY2022Q1 us-gaap Other General Expense
OtherGeneralExpense
185 USD
CY2021Q1 us-gaap Other General Expense
OtherGeneralExpense
0 USD
CY2022Q1 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
0 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-1651 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
436 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1651 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-296435 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-69967 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-296435 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-69967 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
70953905 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
69154308 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70953905 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69154308 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
71843 USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
337500 USD
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
336390 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
449298 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
566955 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
265000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-69967 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
761988 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
296435 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
69967 USD
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1651 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
184 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
185 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
188912 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3008 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5681 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6689 USD
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0 USD
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
644 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-613 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-98650 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62873 USD
CY2022Q1 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
0 USD
CY2021Q1 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
10000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
337500 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
265000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
337500 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
265000 USD
CY2022Q1 vemanti Net Increase In Cash
NetIncreaseInCash
238850 USD
CY2021Q1 vemanti Net Increase In Cash
NetIncreaseInCash
192127 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
295937 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
243494 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
534787 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
435621 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
40000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 vemanti Reclassification Policytextblock
ReclassificationPolicytextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain amounts reported in the prior year condensed consolidated financial statements have been reclassified to conform to the current year’s presentation.</p>
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, among others, allowances for doubtful accounts, valuations for deferred income taxes and recoverability of investments. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved.</p>
CY2021Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
6107 USD
CY2020Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
0 USD
CY2022Q1 vemanti Purchase Of Crypto Currencies
PurchaseOfCryptoCurrencies
0 USD
CY2021 vemanti Purchase Of Crypto Currencies
PurchaseOfCryptoCurrencies
10000 USD
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3893 USD
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71519830 shares
CY2022Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
6107 USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70404086 shares
CY2022Q1 vemanti Stock Issued During Period Shares For Cash
StockIssuedDuringPeriodSharesForCash
631530 shares
CY2022Q1 vemanti Stock Issued During Period Value For Cash
StockIssuedDuringPeriodValueForCash
337500 USD
CY2021Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
6107 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
25142 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
25142 USD

Files In Submission

Name View Source Status
0001477932-22-003338-index-headers.html Edgar Link pending
0001477932-22-003338-index.html Edgar Link pending
0001477932-22-003338.txt Edgar Link pending
0001477932-22-003338-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vemanti-20220331.xsd Edgar Link pending
vemanti-20220331_cal.xml Edgar Link unprocessable
vemanti-20220331_def.xml Edgar Link unprocessable
vemanti-20220331_lab.xml Edgar Link unprocessable
vemanti-20220331_pre.xml Edgar Link unprocessable
vemanti_10q.htm Edgar Link pending
vemanti_10q_htm.xml Edgar Link completed
vemanti_ex311.htm Edgar Link pending
vemanti_ex312.htm Edgar Link pending
vemanti_ex321.htm Edgar Link pending
vemanti_ex322.htm Edgar Link pending